Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. Y. van Sleen

Publicaties

Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis

GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica

Overlapping macrophage immune profiles in polymyalgia rheumatica and giant cell arteritis

Pre-Vaccination Immunotypes and Immune Entropy Are Indicators of Multiple Vaccine Responsiveness

Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis

Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls

Effects of ageing and frailty on circulating monocyte and dendritic cell subsets

Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis

Pers/media

How Does COVID-19 Booster Affect Patients With GCA and Low Primary Vaccine Response?

Biomarkers may improve giant cell arteritis diagnosis

Vasculitis Foundation: international research insights